The Path to Supplier Diversification: Six Key Considerations for Life Science Companies

The need for supplier diversity transcends industries, but life sciences enterprises must be especially vigilant in ensuring they can overcome disruptions and minimize risks. After all, lives are dependent on pharmaceuticals and medical devices.

The Path to Supplier Diversification: Six Key Considerations for Life Science Companies outlines a strategy for partnering with the right suppliers in the right areas to ensure that critical products move swiftly through the supply chain regardless of challenges. 

What’s Inside:

• The value of boosting visibility into Tier 2 suppliers
• The process of evaluating geographical and logistical constraints
• The importance of prioritizing critical products and components

This paper is a must-read for life sciences procurement leaders looking to fortify their supplier diversity strategies.